It’s a new era here at the Hub as we work to find the next Wire champion. Until then, I’ll be guiding you through the frigid early morning deal and PE landscape. So if you have some great stories, as always, hit me up at email@example.com.
Meanwhile, we have some news:
Exit: CenterGate Capital sold The Owen Family of Companies, a specialty environmental equipment platform, to Wynnchurch Capital. CenterGate first invested in Owen in 2018, and since that time the company expanded into new markets, geographies and product offerings, tripling its Ebitda.
CenterGate, formed in 2014 by ex-H.I.G. executives Tiffany Kosch and Stenning Schueppert, closed its debut fund in 2016 on $350 million. In 2015, the firm hired another H.I.G. veteran, Lewis Schoenwetter. Schueppert left in 2018, according to his LinkedIn profile.
CenterGate targets investments in business services, industrials, energy services, consumer and healthcare. Read more here. https://www.pehub.com/centergate-capital-sells-owen-to-wynnchurch/
Regs: Have yins paid attention to the posturing by the SEC around new rules for PE fees and expenses, conflicts, and apparently, side letters? It’s, I believe, the biggest news on the regulatory front in a long time as the SEC can simply make new rules, rather than have to push legislation that is unlikely to make it through Congress (such as, Elizabeth Warren’s vision for a new private equity world).
I found it interesting that SEC chair Gary Gensler said during a keynote hosted by ILPA that the commission was eyeing side letter reforms. I’ve heard for a few years now that side letters have gotten out of control — many LPs ask for them, and other LPs demand ‘most favored nation’ arrangements for transparency into what other LPs are getting on the side.
The review process is burdensome for LPs, all the various requests make for a tough process for GPs, and generally the ones really making out are … take a guess … the lawyers!
Most Favored Nation clauses can work in a variety of ways. Some GPs will grant MFN reviews to every LP in a fund, while others may allow MFN reviews based on size of commitment, I wrote way back in 2015.
The review process has become burdensome, LPs told me at the time. “It used to be that LPs got ‘special’, valuable terms in side letters but everyone learned to require MFN provisions so [the] impact was diminished,” an LP told me at the time. “It’s hard to manage an agreement with lots of different side letters, each with quirks, especially for GPs like Bain with lots of LPs.”
What do you think about side letters, have they gotten out of control (or, maybe more to the point, has the industry figured out how to get them back into control?) Hit me up at firstname.lastname@example.org with your thoughts. I’ll be exploring this issue this week.
That’s it for me! Have a great rest of your day and as always, reach me with tips n’ gossip, feedback and of course, The Drama, at email@example.com or over on LinkedIn.